Currently, early-onset Familial AD-associated mutations in amyloid precursor protein (APP), presenilin 1 (PS1) and presenilin 2 (PS2) were the most commonly used to facilitate the development of translational rodent models of AD. The gene discussed is APP; the disease is Alzheimer disease.